05/05/2021
https://congress.gov...
"High drug prices are really at the top of the mind of our constituents and we've seen recent examples of extreme bad actors raising prices purely for profit motives."
"Congress does need to review and better understand drug pricing to ensure that we are incentivizing research and innovation and development of new drug treatments and cures without creating loopholes ..."
"Because of the leadership of this committee, CMS has announced a plan change to that as of January 1."
"We need an approach that focuses on the patient and the cost to the health care system, which will be tethered by ensuring that there is sufficient competition in the market place."